Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer

Published:2011-08 Issue:9 Volume:11 Page:1131-1133
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Di Maio Massimo

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2011.599799

Reference11 articles.

1. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

2. Necitumumab in the treatment of advanced non-small cell lung cancer: translation from preclinical to clinical development

3. Methodological aspects of lung cancer clinical trials in the era of targeted agents

4. The BATTLE Trial: Personalizing Therapy for Lung Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data;European Journal of Cancer;2023-09

2. The impact of molecular targets in cancer drug development: major hurdles and future strategies;Expert Review of Clinical Pharmacology;2013-01

3. Current World Literature;Current Opinion in Oncology;2012-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP